Gene targeting study on mechanisms for cholesterol accumulation in the artery
Gene targeting study on mechanisms for cholesterol accumulation in the artery
批准号:
07457219
负责人:
YAMADA Nobuhiro
金额:
$4.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
在转基因小鼠或基因敲除小鼠中,可以转导或删除特定基因以研究其功能及其与人类疾病的关系。最近,已经建立了过表达或缺乏特定基因的转基因小鼠或敲除小鼠的各种品系,并可用于研究人类疾病的病理生理学,包括动脉粥样硬化、糖尿病和高脂血症。激素敏感脂肪酶(HSL)是一种多功能酶,可催化脂肪组织中储存的三酰甘油和动脉粥样硬化病变中的胆固醇酯水解。酶的活动是在急性神经元和激素的控制。儿茶酚胺和其他脂解激素通过环腺苷3 ',5'-单磷酸(cAMP)依赖性蛋白激酶(PKA)可逆磷酸化丝氨酸来刺激其活性。相反,胰岛素,一种抗脂解激素,通过阻止磷酸化来抑制其活性。HSL-1<-1->小鼠表现出适度的肥胖、低血脂和对饮食诱导的动脉粥样硬化的极端易感性,这可能是由于主动脉病变中胆固醇酯水解的缺陷。出乎意料的是,我们发现HSL是饥饿时生存所必需的。在HSL-1小鼠中完全不存在响应于禁食的血浆游离脂肪酸(FFA)水平的正常升高<-1->。我们推测FFA的持续供应是维持正常心脏功能所必需的。因此,我们认为HSL是作为一种适应饥饿所需的分子进化而来的,并将肥胖与动脉粥样硬化联系起来。
英文摘要
In the transgenic mouse or knockout mouse, a specific gene can be transduced or deleted to study its function and relation to human diseases. Recently, various lines of transgenic mice or knockout mice which overexpress or lack a specific gene have been established and are available to study the pathophysiology of human diseases, including atherosclerosis, diabetes mellitus, and hyperlipidemia. Hormone-sensitive lipase (HSL) is a multi-functional enzyme which catalyzes the hydrolysis of triacylglycrol stored in adipose tissue and cholesterol esters in atherosclerotic lesions. The enzymatic activities are under acute neuronal and hormonal control. Catecholamines and other lipolytic hormones stimulate its activities through reversible phosphorylation of serine by cyclic adenosine 3', 5'-monophosphate (cAMP)-dependent protein kinase (PKA). Conversely, insulin, an anti-lipolytic hormone, suppresses its activities through preventing the phosphorylation. HSL^<-1-> mice exhibited modest obesity, hypolipidemia and extreme susceptibility to diet-induced atherosclerosis probably due to the defect in hydrolysis of cholesterol ester in the aortic lesions. Unexpectedly, we found that HSL is essential for survival upon starvation. Normal rise in plasma free fatty acids (FFA) levels in response to fasting is completely absent in HSL^<-1-> mice. We speculate that a continuous supply of FFA is required to sustain normal cardiac function. Thus, we propose that HSL is evolved as a molecule needed for adaptation to starvation and links obesity to atherosclerosis.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
山田信博,他: "Transcription factor PU.1 mediates the induction of c-fms in vascular smooth muscle cells : A mechanism for phenotypical change to phagocytic cells." Mol Cell Biol.16. 2264-2273 (1996)
Nobuhiro Yamada 等人:“转录因子 PU.1 介导血管平滑肌细胞中 c-fms 的诱导:吞噬细胞表型变化的机制。”16 (1996)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H Abe, Y Bandai, M Maku-uchi, Y Idezaki, M Nozawa, Y Oka, J Ohsuga, Y Watanabe, T Inaba, N Yamada: "Hyperinsulinemia accelerates accumulation of cholesterol ester in aorta of rats with transplanted pancreas" Diabetologia. 39. 1276-1283 (1996)
H Abe、Y Bandai、M Maku-uchi、Y Idezaki、M Nozawa、Y Oka、J Ohsuga、Y Watanabe、T Inaba、N Yamada:“高胰岛素血症加速胰腺移植大鼠主动脉中胆固醇酯的积累”糖尿病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
山田信博,他: "Enhanced expression of platelet-derived growth factor-β receptor by high glucose : involvement of platelet-derived growth factor in diabetic angiopathy" Diabetes. 45. 507-512 (1996)
Nobuhiro Yamada 等人:“高葡萄糖增强血小板衍生生长因子-β 受体的表达:血小板衍生生长因子参与糖尿病血管病”糖尿病。 45. 507-512 (1996)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
山田信博等: "Overexpression of apolipoprotein E prevents the development of diabetic hyperlipidemia in transgenic mice" Diabetes. 44. 580-585 (1995)
Nobuhiro Yamada 等人:“载脂蛋白 E 的过度表达可预防转基因小鼠糖尿病性高脂血症的发生”,糖尿病。 44. 580-585 (1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T Inaba, S Ishibashi, T Gotoda, M Kawamura, N Morino, Y Nojima, M Kawakami, Y Yazaki, N Yamada: "Enhanced expression of platelet-derived growth factor-beta receptor by high glucose : involvement of platelet-derived growth factor in diabetic angiopathy" Di
T Inaba、S Ishibashi、T Gotoda、M Kawamura、N Morino、Y Nojima、M Kawakami、Y Yazaki、N Yamada:“高葡萄糖增强血小板衍生生长因子-β 受体的表达:血小板衍生生长因子的参与
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 24 条
Global survey on clinical research supporting and promoting system, aiming Japanese clinical research improvement.
-
批准号:19900005
-
项目类别:Grant-in-Aid for Special Purposes
-
资助金额:$5.76万
-
财政年份:2007
-
负责人:YAMADA Nobuhiro
-
依托单位:
Transcriptional regulation of energy metabolism in metabolic syndrome.
-
批准号:18390268
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.17万
-
财政年份:2006
-
负责人:YAMADA Nobuhiro
-
依托单位:
Animal model for metabolic syndrome and its molecular basis.
-
批准号:16390260
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.22万
-
财政年份:2004
-
负责人:YAMADA Nobuhiro
-
依托单位:
Regulation of signaling pathway, cell cycle, and cell growth in atherosclerosis
-
批准号:13470221
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:2001
-
负责人:YAMADA Nobuhiro
-
依托单位:
Roles of fatty acids in pathogenesis of insulin resisitance and atherosclerosis
-
批准号:11470231
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$9.34万
-
财政年份:1999
-
负责人:YAMADA Nobuhiro
-
依托单位:
Molecular biology of form cell generation in atherosclerosis
-
批准号:09470216
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.38万
-
财政年份:1997
-
负责人:YAMADA Nobuhiro
-
依托单位:
Development of animal models for atherosclerosis and obesity, and molecular mechanism of the common pathway
-
批准号:09557079
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.49万
-
财政年份:1997
-
负责人:YAMADA Nobuhiro
-
依托单位:
Establishment of animal models for atheroscherosis and gene therapy
-
批准号:05557049
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$9.79万
-
财政年份:1993
-
负责人:YAMADA Nobuhiro
-
依托单位:
Therapeutic trial of atherosclerosis by M-CSF
-
批准号:02557110
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$9.47万
-
财政年份:1990
-
负责人:YAMADA Nobuhiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ACAT-1介导胆固醇酯蓄积在宫颈癌细胞内的促癌机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:毛世杰
-
依托单位:
益肾清利活血方调控ACAT1乙酰化修饰TFEB修复自噬流改善肾纤维化的机制研究
-
批准号:82374373
-
项目类别:面上项目
-
资助金额:45万元
-
批准年份:2023
-
负责人:孙伟
-
依托单位:
ACAT1通过内质网-线粒体互作调控线粒体稳态在棕色脂肪细胞中的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:周章森
-
依托单位:
ACAT1作为CHK1抑制剂抗急性髓系白血病耐药生物标志物和联用靶点的探索性研究
-
批准号:82304539
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:姜凯龙
-
依托单位:
基于ACAT2/FASN/AcAc-CoA调控轴探讨促进脂肪酸合成代谢对抗血管内皮衰老的分子机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:罗文威
-
依托单位:
ACAT1通过溶酶体途径抑制脑出血后小胶质细胞持续吞噬能力的作用和机制研究
-
批准号:82371299
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈高
-
依托单位:
乳腺癌CDK4/6抑制剂耐药新机制:ACAT2代谢物Meta2靶向调控YAP构象及活性促进其核转位的机制研究
-
批准号:82303834
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:孙茜
-
依托单位:
AhR通过促进ACAT1转录介导肺癌细胞奥希替尼耐药的机制研究
-
批准号:2023JJ60078
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:陈一川
-
依托单位:
代谢酶ACAT1核转位激活NF-κB发挥非经典生物学功能增强结直肠癌免疫治疗敏感性的机制研究
-
批准号:82303224
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:孟奇
-
依托单位:
ACAT1蛋白第263位赖氨酸琥珀酰化在ARID1A突变型卵巢癌发生发展中的生物学功能及分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:周圣涛
-
依托单位: